Lorca T, Cruzalegui F H, Fesquet D, Cavadore J C, Méry J, Means A, Dorée M
Centre National de la Recherche Scientifique, Montpellier, France.
Nature. 1993 Nov 18;366(6452):270-3. doi: 10.1038/366270a0.
In vertebrates, unfertilized eggs are arrested at second meiotic metaphase by a cytostatic factor (CSF), an essential component of which is the product of the c-mos proto-oncogene. CSF prevents ubiquitin-dependent degradation of mitotic cyclins and thus inactivation or the M phase-promoting factor (MPF). Fertilization or parthenogenetic activation triggers a transient increase in the cytoplasmic free Ca2+ (reviewed in refs 5 and 6), inactivates both CSF and MPF, and releases eggs from meiotic metaphase arrest. A calmodulin-dependent process is required for cyclin degradation to occur in cell-free extracts prepared from metaphase II-arrested eggs (CSF extracts) when the free Ca2+ concentration is transiently raised in the physiological micromolar range. Here we show that when a constitutively active mutant of calmodulin-dependent protein kinase II (CaM KII) is added to a CSF extract, cyclin degradation and Cdc2 kinase inactivation occur even in the absence of Ca2+, and the extract loses its ability to cause metaphase arrest when transferred into embryos. Furthermore, specific inhibitors of CaM KII prevent cyclin degradation after calcium addition. Finally, the direct microinjection of constitutively active CaM KII into unfertilized eggs inactivates Cdc2 kinase and CSF, even in the absence of a Ca2+ transient. The target for Ca(2+)-calmodulin is thus CaM KII.
在脊椎动物中,未受精的卵被一种细胞静止因子(CSF)阻滞在减数第二次分裂中期,该因子的一个重要组成部分是原癌基因c-mos的产物。CSF可防止有丝分裂周期蛋白通过泛素依赖性途径降解,从而使促成熟因子(MPF)失活或维持其活性。受精或孤雌生殖激活会引发细胞质游离Ca2+的短暂升高(参考文献5和6中有综述),使CSF和MPF均失活,并使卵从减数分裂中期阻滞中释放出来。当游离Ca2+浓度在生理微摩尔范围内短暂升高时,在从中期II阻滞的卵制备的无细胞提取物(CSF提取物)中,周期蛋白的降解需要一个钙调蛋白依赖性过程。在此我们表明,当将钙调蛋白依赖性蛋白激酶II(CaM KII)的组成型活性突变体添加到CSF提取物中时,即使在没有Ca2+的情况下,周期蛋白也会降解,Cdc2激酶失活,并且当将该提取物注入胚胎时,它失去了导致中期阻滞的能力。此外,CaM KII的特异性抑制剂可防止添加钙后周期蛋白的降解。最后,将组成型活性CaM KII直接显微注射到未受精的卵中,即使在没有Ca2+瞬变的情况下,也能使Cdc2激酶和CSF失活。因此,Ca(2+)-钙调蛋白的作用靶点是CaM KII。